This article presents a strategy for the initial step of data harmonization in Individual Participant Data syntheses, i.e., making decisions as to which measures operationalize the constructs of interest - and which do not. This step is vital in the process of data harmonization, because a study can only be as good as its measures. If the construct validity of the measures is in question, study results are questionable as well. Our proposed strategy for data harmonization consists of three steps. First, a unitary construct is defined based on the existing literature, preferably on the theoretical framework surrounding the construct. Second, the various instruments used to measure the construct are evaluated as operationalizations of this construct, and retained or excluded based on this evaluation. Third, the scores of the included measures are recoded on the same metric. We illustrate the use of this method with three example constructs focal to the Collaboration on Attachment Transmission Synthesis (CATS) study: parental sensitivity, child temperament, and social support. This process description may aid researchers in their data pooling studies, filling a gap in the literature on the first step of data harmonization.•Data harmonization in studies using combined datasets is of vital importance for the validity of the study results.•We have developed and illustrated a strategy on how to define a unitary construct and evaluate whether instruments are operationalizations of this construct as the initial step in the harmonization process.•This strategy is a transferable and reproducible method to apply to the data harmonization process.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637952 | PMC |
http://dx.doi.org/10.1016/j.mex.2022.101889 | DOI Listing |
BMC Med Inform Decis Mak
January 2025
Higher Institute of Medical Technology, Yaoundé, Cameroon.
Background: In Cameroon, like in many other resource-limited countries, data generated by health settings including morbidity and mortality parameters are not always uniform. In the absence of a national guideline necessary for the standardization and harmonization of data, precision of data required for effective decision-making is therefore not guaranteed. The objective of the present study was to assess the reporting style of morbidity and mortality data in healthcare settings.
View Article and Find Full Text PDFBMC Vet Res
January 2025
Norwegian Veterinary Institute, Elizabeth Stephansens Vei 1, Ås, 1433, Norway.
Background: Vaccination of farmed salmonids has been an integral part of preventing infectious diseases in Norway's aquaculture industry. In Norway, vaccine usage is regulated by the government. There is a need to monitor vaccine usage for both regulatory and research purposes, at local and national scales.
View Article and Find Full Text PDFPharmacoepidemiol Drug Saf
January 2025
Aetion Inc., New York, New York, USA.
Purpose: To characterize select laboratory tests ordered versus reported for patients diagnosed with COVID-19 in administrative healthcare and commercial laboratory data.
Methods: Among patients with an outpatient COVID-19 diagnosis claim in HealthVerity data (01/01/2021-12/31/2022), this study described baseline characteristics and descriptively compared SARS-CoV-2 diagnostic tests and liver function tests from administrative healthcare (insurance claims and hospital billing data) and commercial laboratories, overall and by code type (e.g.
PLoS One
January 2025
Woodwell Climate Research Center, Falmouth, MA, United States of America.
Soil spectroscopy is a widely used method for estimating soil properties that are important to environmental and agricultural monitoring. However, a bottleneck to its more widespread adoption is the need for establishing large reference datasets for training machine learning (ML) models, which are called soil spectral libraries (SSLs). Similarly, the prediction capacity of new samples is also subject to the number and diversity of soil types and conditions represented in the SSLs.
View Article and Find Full Text PDFImportance: Cardiovascular health outcomes associated with noncigarette tobacco products (cigar, pipe, and smokeless tobacco) remain unclear, yet such data are required for evidence-based regulation.
Objective: To investigate the association of noncigarette tobacco products with cardiovascular health outcomes.
Design, Setting, And Participants: This cohort study was conducted within the Cross Cohort Collaboration Tobacco Working Group by harmonizing tobacco-related data and conducting a pooled analysis from 15 US-based prospective cohorts with data on the use of at least 1 noncigarette tobacco product ranging between 1948 and 2015.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!